Abstract
Background
Phase transition and phase separation as well as their tipping points are penetrating phenomena in biology and are intrinsic properties of biological systems ranging from basic molecule complexes to cells and all way up to entire ecosystems.
Results
For example, phase separation has been established as a key mechanism for biological molecules such as protein or RNA to form membraneless organelles to perform complex biological functions. Phase transitions are commonly observed during cellular differentiation, and generally, there are the tipping points or critical states just before the phase transitions. And the stability of ecosystem and extinction of species are systematic manifestation of phase transitions. All phase transition and phase separation phenomena display switch-like behavior and critical transitions.
Conclusion
Here we summarize the concepts regarding the epithelial-to-mesenchymal transition (EMT) as a type of phase changes and the implication of critical transitions in EMT, and discuss open questions and challenges in this fast-moving field.
Article PDF
Similar content being viewed by others
References
Stanley, H. E. (1987) Introduction to Phase Transitions and Critical Phenomena, pp. 308. New York: Oxford University Press
Chen, L., Liu, R., Liu, Z. P., Li, M. and Aihara, K. (2012) Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci. Rep., 2, 342
Liu, R., Chen, P., Aihara, K. and Chen, L. (2015) Identifying early-warning signals of critical transitions with strong noise by dynamical network markers. Sci. Rep., 5, 17501
Honig, J. and Spalek, J. (2017) A Primer to the Theory of Critical Phenomena, 1st edition, Waltham, M.A. (ed.). Elsevier
Haldane, A. G. and May, R. M. (2011) Systemic risk in banking ecosystems. Nature, 469, 351–355
Dai, L., Vorselen, D., Korolev, K. S. and Gore, J. (2012) Generic indicators for loss of resilience before a tipping point leading to population collapse. Science, 336, 1175–1177
Scheffer, M., Carpenter, S. R., Lenton, T. M., Bascompte, J., Brock, W., Dakos, V., van de Koppel, J., van de Leemput, I. A., Levin, S. A., van Nes, E. H., et al. (2012) Anticipating critical transitions. Science, 338, 344–348
Veraart, A. J., Faassen, E. J., Dakos, V., van Nes, E. H., Lürling, M. and Scheffer, M. (2012) Recovery rates reflect distance to a tipping point in a living system. Nature, 481, 357–359
Boija, A., Klein, I. A., Sabari, B. R., Dall’Agnese, A., Coffey, E. L., Zamudio, A. V., Li, C. H., Shrinivas, K., Manteiga, J. C., Hannett, N. M., et al. (2018) Transcription factors activate genes through the phase-separation capacity of their activation domains. Cell, 175, 1842–1855.e16
Yang, J. and Weinberg, R. A. (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell, 14, 818–829
Thiery, J. P., Acloque, H., Huang, R. Y. and Nieto, M. A. (2009) Epithelial-mesenchymal transitions in development and disease. Cell, 139, 871–890
Revenu, C. and Gilmour, D. (2009) EMT 2.0: shaping epithelia through collective migration. Curr. Opin. Genet. Dev., 19, 338–342
Nieto, M. A., Huang, R. Y., Jackson, R. A. and Thiery, J. P. (2016) EMT: 2016. Cell, 166, 21–45
Kalluri, R. and Weinberg, R. A. (2009) The basics of epithelial-mesenchymal transition. J. Clin. Invest., 119, 1420–1428
Hay, E. D. (1995) An overview of epithelio-mesenchymal transformation. Acta Anat., (Basel), 154, 8–20
Chao, Y., Wu, Q., Acquafondata, M., Dhir, R. and Wells, A. (2012) Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron., 5, 19–28
Goetz, H., Melendez-Alvarez, J. R., Chen, L. and Tian, X. J. (2020) A plausible accelerating function of intermediate states in cancer metastasis. PLOS Comput. Biol., 16, e1007682
Scheel, C. and Weinberg, R. A. (2012) Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol., 22, 396–403
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science, 339, 580–584
Ryu, H. S., Park, D. J., Kim, H. H., Kim, W. H. and Lee, H. S. (2012) Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Hum. Pathol., 43, 520–528
Chen, L., Gibbons, D. L., Goswami, S., Cortez, M. A., Ahn, Y. H., Byers, L. A., Zhang, X., Yi, X., Dwyer, D., Lin, W., et al. (2014) Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat. Commun., 5, 5241
Liu, Y., Xue, M., Du, S., Feng, W., Zhang, K., Zhang, L., Liu, H., Jia, G., Wu, L., Hu, X., et al. (2019) Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT. Nat. Commun., 10, 1637
Chang, H., Liu, Y., Xue, M., Liu, H., Du, S., Zhang, L. and Wang, P. (2016) Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition. Nucleic Acids Res., 44, 2514–2527
Taube, J. H., Herschkowitz, J. I., Komurov, K., Zhou, A. Y., Gupta, S., Yang, J., Hartwell, K., Onder, T. T., Gupta, P. B., Evans, K. W., et al. (2010) Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc. Natl. Acad. Sci. USA, 107, 15449–15454
Javaid, S., Zhang, J., Anderssen, E., Black, J. C., Wittner, B. S., Tajima, K., Ting, D. T., Smolen, G. A., Zubrowski, M., Desai, R., et al. (2013) Dynamic chromatin modification sustains epithelialmesenchymal transition following inducible expression of Snail-1. Cell Rep., 5, 1679–1689
Tian, X. J., Zhang, H. and Xing, J. (2013) Coupled reversible and irreversible bistable switches underlying TGF-β-induced epithelial to mesenchymal transition. Biophys. J., 105, 1079–1089
Zhang, J., Tian, X. J., Zhang, H., Teng, Y., Li, R., Bai, F., Elankumaran, S. and Xing, J. (2014) TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops. Sci. Signal., 7, ra91
Liu, Y., Xue, M., Du, S., Feng, W., Zhang, K., Zhang, L., Liu, H., Jia, G., Wu, L., Hu, X., et al. (2019) Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT. Nat. Commun., 10, 1637
Yang, M., Li, S. N., Anjum, K. M., Gui, L. -X., Zhu, S. -S., Liu, J., Chen, J. -K., Liu, Q. -F., Ye, G. -D., Wang, W. -J., et al. (2013) A double-negative feedback loop between Wnt-beta-catenin signaling and HNF4alpha regulates epithelial-mesenchymal transition in hepatocellular carcinoma. J. Cell Sci., 126, 5692–5703
Liu, R., Yu, X., Liu, X., Xu, D., Aihara, K. and Chen, L. (2014) Identifying critical transitions of complex diseases based on a single sample. Bioinformatics, 30, 1579–1586
Chen, P., Liu, R., Li, Y. and Chen, L. (2016) Detecting critical state before phase transition of complex biological systems by hidden Markov model. Bioinformatics, 32, 2143–2150
Liu, X., Chang, X., Liu, R., Yu, X., Chen, L. and Aihara, K. (2017) Quantifying critical states of complex diseases using single-sample dynamic network biomarkers. PLOS Comput. Biol., 13, e1005633
De Craene, B. and Berx, G. (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer, 13, 97–110
Gregory, P. A., Bracken, C. P., Smith, E., Bert, A. G., Wright, J. A., Roslan, S., Morris, M., Wyatt, L., Farshid, G., Lim, Y. Y., et al. (2011) An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol. Biol. Cell, 22, 1686–1698
Hajra, K. M., Chen, D. Y. and Fearon, E. R. (2002) The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res., 62, 1613–1618
Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., van Roy, F. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol., Cell, 7, 1267–1278
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y. and Goodall, G. J. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol., 10, 593–601
Xiao, P., Liu, W. and Zhou, H. (2016) miR-200b inhibits migration and invasion in non-small cell lung cancer cells via targeting FSCN1. Mol. Med. Rep., 14, 1835–1840
Williams, L. V., Veliceasa, D., Vinokour, E. and Volpert, O. V. (2013) miR-200b inhibits prostate cancer EMT, growth and metastasis. PLoS One, 8, e83991
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S. and Brabletz, T. (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep., 9, 582–589
Yang, B., Li, M., Tang, W., Liu, W., Zhang, S., Chen, L. and Xia, J. (2018) Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma. Nat. Commun., 9, 678
Li, M., Li, C., Liu, W.-X., Liu, C., Cui, J., Li, Q., Ni, H., Yang, Y., Wu, C., Chen, C., et al. (2017) Dysfunction of PLA2G6 and CYP2C44-associated network signals imminent carcinogenesis from chronic inflammation to hepatocellular carcinoma. J. Mol. Cell Biol., 9, 489–503
Liu, X., Chang, X., Leng, S., Tang, H., Aihara, K. and Chen, L. (2019) Detection for disease tipping points by landscape dynamic network biomarkers. Natl. Sci. Rev., 6, 775–785
Liu, R., Wang, J., Ukai, M., Sewon, K., Chen, P., Suzuki, Y., Wang, H., Aihara, K., Okada-Hatakeyama, M. and Chen, L. (2019) Hunt for the tipping point during endocrine resistance process in breast cancer by dynamic network biomarkers. J. Mol. Cell. Biol., 11, 649–664
Richard, A., Boullu, L., Herbach, U., Bonnafoux, A., Morin, V., Vallin, E., Guillemin, A., Papili Gao, N., Gunawan, R., Cosette, J., et al. (2016) Single-cell-based analysis highlights a surge in cell-to-cell molecular variability preceding irreversible commitment in a differentiation process. PLoS Biol., 14, e1002585
Lesterhuis, W. J., Bosco, A., Millward, M. J., Small, M., Nowak, A. K. and Lake, R. A. (2017) Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity. Nat. Rev. Drug Discov., 16, 264–272
Li, M., Zeng, T., Liu, R. and Chen, L. (2013) Detecting tissue-specific early-warning signals for complex diseases based on dynamical network biomarkers: study of type-2 diabetes by cross-tissue analysis. Brief. Bioinform., 15, 229–243
Zhao, J., Zhou, Y., Zhang, X. and Chen, L. (2016) Part mutual information for quantifying direct associations in networks. Proc. Natl. Acad. Sci. USA, 113, 5130–5135
Zhang, X., Zhao, J., Hao, J.-K., Zhao, X.-M. and Chen, L. (2015) Conditional mutual inclusive information enables accurate quantification of associations in gene regulatory networks. Nucleic Acids Res., 43, e31
Ma, H., Leng, S., Aihara, K., Lin, W. and Chen, L. (2018) Randomly distributed embedding making short-term high-dimensional data predictable. Proc. Natl. Acad. Sci. USA, 115, E9994–E10002
Sa, R., Zhang, W., Ge, J., Wei, X., Zhou, Y., Landzberg, D. R., Wang, Z., Han, X., Chen, L. and Yin, H. (2016) Discovering a critical transition state from nonalcoholic hepatosteatosis to nonalcoholic steatohepatitis by lipidomics and dynamical network biomarkers. J. Mol. Cell Biol., 8, 195–206
Jiang, Z., Lu, L., Liu, Y., Zhang, S., Li, S., Wang, G., Wang, P. and Chen, L. (2020) SMAD7 and SERPINE1 as novel dynamic network biomarkers detect and regulate the tipping point of TGF-beta induced EMT. Sci. Bull., 65, 842–853
Acknowledgements
The authors apologize to those colleagues whose relevant studies were not cited owing to space limitations. This work was supported in part by the Strategic Priority Research Program of the Chinese Academy of Sciences (No. XDB38040400), the National Natural Science Foundation of China (Nos. 31930022, 31671380 and 31771476), and Shanghai Municipal Science and Technology Major Project (No. 2017SHZDZX01).
Author information
Authors and Affiliations
Corresponding author
Additional information
Compliance with Ethics Guidelines
The authors Peng Wang and Luonan Chen declare that they have no conflict of interests.
This article is a review article and does not contain any studies with human or animal subjects performed by any of the authors.
Rights and permissions
About this article
Cite this article
Wang, P., Chen, L. Critical transitions and tipping points in EMT. Quant Biol 8, 195–202 (2020). https://doi.org/10.1007/s40484-020-0219-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40484-020-0219-0